valproic acid has been researched along with Adult Neuroaxonal Dystrophy in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serum concentrations of valproate were reduced and seizures were exacerbated by concomitant meropenem therapy in a child with a neurodegenerative disorder and epilepsy." | 3.73 | Seizure worsening caused by decreased serum valproate during meropenem therapy. ( Parmeggiani, A; Riva, R; Santucci, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santucci, M | 1 |
| Parmeggiani, A | 1 |
| Riva, R | 1 |
1 other study available for valproic acid and Adult Neuroaxonal Dystrophy
| Article | Year |
|---|---|
Seizure worsening caused by decreased serum valproate during meropenem therapy.
Topics: Anti-Bacterial Agents; Anticonvulsants; Child; Drug Interactions; Epilepsy; Female; Humans; Meropene | 2005 |